ClinVar Miner

Submissions for variant NM_002691.4(POLD1):c.2574G>T (p.Glu858Asp)

gnomAD frequency: 0.00001  dbSNP: rs1060501820
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 2
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Invitae RCV000457858 SCV000547552 uncertain significance Colorectal cancer, susceptibility to, 10 2023-08-10 criteria provided, single submitter clinical testing In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt POLD1 protein function. ClinVar contains an entry for this variant (Variation ID: 408005). This variant has not been reported in the literature in individuals affected with POLD1-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change replaces glutamic acid, which is acidic and polar, with aspartic acid, which is acidic and polar, at codon 858 of the POLD1 protein (p.Glu858Asp).
Victorian Clinical Genetics Services, Murdoch Childrens Research Institute RCV002470859 SCV002769325 uncertain significance Mandibular hypoplasia-deafness-progeroid syndrome 2020-05-21 criteria provided, single submitter clinical testing A heterozygous missense variant was identified, NM_001256849.1(POLD1):c.2574G>T in exon 21 of 27 of the POLD1 gene. This substitution is predicted to create a minor amino acid change from a glutamic acid to an aspartic acid at position 858 of the protein; NP_001243778.1(POLD1):p.(Glu858Asp). The glutamic acid at this position has low conservation (100 vertebrates, UCSC), but is located within the polymerase active site region (Weedon, M. N. et al. (2013)). In silico software predicts this variant to be tolerated (PolyPhen2, SIFT, CADD, Mutation Taster). The variant is not present in the gnomAD population database. This variant has been previously been reported as a VUS (ClinVar). Based on information available at the time of curation, this variant has been classified as a VUS with LOW CLINICAL RELEVANCE. Legend: (P) - Pathogenic, (N) - Neutral, (B) - Benign

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.